
Supernus, Inc.: shareholders and insiders
Price
$28.96
November 18, 2026Market cap $3.4B
What Ploutos Investor adds for Supernus
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from 2021
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Jan 5, 2026 to Nov 4, 2026, from their own Form 4 filings.
Insider trades start on January 7, 2026
Until lately Supernus was a foreign company listed in the US. Officers of foreign companies do not report their purchases and sales, so there are none before. They are not missing on our side: they were never filed.
- Until 2024Foreign company (annual report on 20-F)
- March 2025Becomes a US filer (annual report on 10-K)
- January 7, 2026The first insider trade report (Form 4)
Bought on the market
$311.6K
7 people
Sold on the market
$2.8M
2 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
- Nov 2, 2026Frank MottolaSVP, Chief Tech. Ops. OfficerKind
- Nov 2, 2026Timothy C DecSVP, Chief Financial OfficerKind
- Nov 2, 2026Carrolee BarlowDirectorKind
- Nov 2, 2026Padmanabh P. BhattSVP of IP, CSOKind
- Nov 2, 2026Georges GemayelDirectorKind
- Nov 2, 2026Jack A. KhattarChief Executive OfficerKind
- Nov 2, 2026Jack A. KhattarChief Executive OfficerKind
- Nov 2, 2026Jonathan RubinSVP, Chief Medical OfficerKind
- Aug 27, 2026Woodrow D AndersonChief Accounting OfficerKind
- Aug 5, 2026Woodrow D AndersonChief Accounting OfficerKind
- Jul 10, 2026Christian HeidbrederChief Scientific OfficerKind10b5-1
- Jun 22, 2026Joseph CiaffoniChief Executive OfficerKind
- Jun 22, 2026Joseph CiaffoniChief Executive OfficerKind
- Jun 11, 2026Christian HeidbrederChief Scientific OfficerKind10b5-1
- Jun 8, 2026Ryan PreblickChief Financial OfficerKind10b5-1
- Mar 13, 2026Barbara RyanKind
- Mar 9, 2026Barbara RyanKind
- Mar 6, 2026Stuart A KingsleyKind
- Jan 5, 2026Daniel A NinivaggiKind10b5-1
- Jan 5, 2026Mark StejbachKind10b5-1
- Jan 5, 2026David E. WheadonKind10b5-1
- Jan 5, 2026Barbara RyanKind10b5-1
- Jan 5, 2026Keith HumphreysKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Frank MottolaSVP, Chief Tech. Ops. Officer | 30.1K | – | – | Form 4 | |
| Nov 2, 2026 | Timothy C DecSVP, Chief Financial Officer | 14.1K | – | – | Form 4 | |
| Nov 2, 2026 | Carrolee BarlowDirector | 41.7K | – | – | Form 4 | |
| Nov 2, 2026 | Padmanabh P. BhattSVP of IP, CSO | 28.7K | – | – | Form 4 | |
| Nov 2, 2026 | Georges GemayelDirector | 42.0K | – | – | Form 4 | |
| Nov 2, 2026 | Jack A. KhattarChief Executive Officer | 1.94M | – | – | Form 4 | |
| Nov 2, 2026 | Jack A. KhattarChief Executive Officer | 1.48M | – | – | Form 4 | |
| Nov 2, 2026 | Jonathan RubinSVP, Chief Medical Officer | 21.5K | – | – | Form 4 | |
| Aug 27, 2026 | Woodrow D AndersonChief Accounting Officer | 1,500 | $35.69 | $53.5K | Form 4 | |
| Aug 5, 2026 | Woodrow D AndersonChief Accounting Officer | 1,500 | $36.28 | $54.4K | Form 4 | |
| Jul 10, 2026 | Christian HeidbrederChief Scientific Officer | 10b5-1 | 18.6K | $41.14 | $764.6K | Form 4 |
| Jun 22, 2026 | Joseph CiaffoniChief Executive Officer | 1.27M | – | – | Form 4 | |
| Jun 22, 2026 | Joseph CiaffoniChief Executive Officer | 612.5K | $38.32 | $23M | Form 4 | |
| Jun 11, 2026 | Christian HeidbrederChief Scientific Officer | 10b5-1 | 18.6K | $38.06 | $707.4K | Form 4 |
| Jun 8, 2026 | Ryan PreblickChief Financial Officer | 10b5-1 | 36.0K | $37.70 | $1.4M | Form 4 |
| Mar 13, 2026 | Barbara Ryan | 8 | $31.09 | $249 | Form 4 | |
| Mar 9, 2026 | Barbara Ryan | 31 | $32.56 | $1.0K | Form 4 | |
| Mar 6, 2026 | Stuart A Kingsley | 940 | $31.87 | $30.0K | Form 4 | |
| Jan 5, 2026 | Daniel A Ninivaggi | 10b5-1 | 775 | $35.39 | $27.4K | Form 4 |
| Jan 5, 2026 | Mark Stejbach | 10b5-1 | 775 | $35.39 | $27.4K | Form 4 |
| Jan 5, 2026 | David E. Wheadon | 10b5-1 | 1,771 | $35.39 | $62.7K | Form 4 |
| Jan 5, 2026 | Barbara Ryan | 10b5-1 | 775 | $35.39 | $27.4K | Form 4 |
| Jan 5, 2026 | Keith Humphreys | 10b5-1 | 775 | $35.39 | $27.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 10, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class14.3%
- Vanguard Portfolio ManagementShare of class6.55%
- Millennium Management LLCwith 2 more personsShare of class5.40%
- Vanguard Capital ManagementShare of class5.35%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.3% | 17.81M | Jan 8, 20262 filings since Jul 17, 2025 | 13G/A | |
| Vanguard Portfolio Management | 6.55% | 7.99M | Apr 28, 2026 | 13G | |
| Millennium Management LLCwith 2 more persons | 5.40% | 6.34M | Sep 30, 20263 filings since Dec 22, 2025 | 13G | |
| Vanguard Capital Management | 5.35% | 6.52M | Apr 27, 2026 | 13G |
Fell to 5% or less (7)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Oaktree Value Opportunities Fund, L.P.13D0.76%Aug 13, 202613D/A
- Madison Avenue International LP3.50%May 15, 202613G/A
- Fuller & Thaler Asset Management, Inc.3.72%May 13, 202613G/A
- The Goldman Sachs Group2.90%Feb 12, 202613G/A
- Two Seas Capital LP13D4.98%Dec 23, 202513D/A
- Deerfield Mgmt, L.P.3.70%Nov 13, 202513G/A
- Morgan Stanley3.70%May 6, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter-23%
- Millennium Mgmt (Englander)In the quarter-49%
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter-40%
- D.E. ShawIn the quarter-27%
- AQR CapitalIn the quarter-71%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 1.13M | -23% | $49M | 0.07% |
| Millennium Mgmt (Englander) | 1.97M | -49% | $85M | 0.06% |
| Point72 (Cohen) | 543.0K | $23M | 0.04% | |
| Citadel Advisors (Griffin) | 828.9K | -40% | $36M | 0.02% |
| D.E. Shaw | 560.5K | -27% | $24M | 0.02% |
| AQR Capital | 25.5K | -71% | $1.1M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short sales in daily trading
How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.
In the last 13 sessions, 61.8% of the shares in the reported trades were short sales, against 60.7% in the 14 before.
- Last 13 sessionsOct 30, 2026 – Nov 18, 2026
- 61.8%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 60.7%
- Change
- +1.1 pts
- Short sales a dayon average, of 1.55M shares
- 959.3K
- More than atof 3,656 US-listed companies, same days
- 86%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 60.4%
- Oct 13, 2026: Short sales 44.6%
- Oct 14, 2026: Short sales 64.1%
- Oct 15, 2026: Short sales 69.7%
- Oct 16, 2026: Short sales 50.6%
- Oct 19, 2026: Short sales 61.2%
- Oct 20, 2026: Short sales 52.7%
- Oct 21, 2026: Short sales 73.9%
- Oct 22, 2026: Short sales 56.2%
- Oct 23, 2026: Short sales 49.5%
- Oct 26, 2026: Short sales 56.2%
- Oct 27, 2026: Short sales 69.7%
- Oct 28, 2026: Short sales 71.5%
- Oct 29, 2026: Short sales 73.3%
- Oct 30, 2026: Short sales 82.4%
- Nov 3, 2026: Short sales 52%
- Nov 4, 2026: Short sales 57.2%
- Nov 5, 2026: Short sales 53.8%
- Nov 6, 2026: Short sales 51.6%
- Nov 9, 2026: Short sales 58.7%
- Nov 10, 2026: Short sales 63.1%
- Nov 11, 2026: Short sales 64.2%
- Nov 12, 2026: Short sales 79.8%
- Nov 13, 2026: Short sales 74%
- Nov 16, 2026: Short sales 75.2%
- Nov 17, 2026: Short sales 67.3%
- Nov 18, 2026: Short sales 53%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Jack A. KhattarChief Executive OfficerDirectly3.41M
- Joseph CiaffoniChief Executive OfficerDirectly790.3K
- Ryan PreblickChief Financial OfficerDirectly284.8K
- Christian HeidbrederChief Scientific OfficerDirectly209.3K
- Georges GemayelDirectorDirectly42.0K
- Carrolee BarlowDirectorDirectly41.7K
- Frank MottolaSVP, Chief Tech. Ops. OfficerDirectly30.1K
- Padmanabh P. BhattSVP of IP, CSODirectly28.7K
- Woodrow D AndersonChief Accounting OfficerDirectly27.6K
- Jonathan RubinSVP, Chief Medical OfficerDirectly21.5K
- Timothy C DecSVP, Chief Financial OfficerDirectly14.1K
- Barbara RyanDirectorDirectly5,724
- Stuart A KingsleyDirectorDirectly5,582
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Jack A. KhattarChief Executive Officer | 3.41M | – | Nov 2, 2026 | Form 4 |
| Joseph CiaffoniChief Executive Officer | 790.3K | – | Jun 22, 2026 | Form 4 |
| Ryan PreblickChief Financial Officer | 284.8K | – | Jun 8, 2026 | Form 4 |
| Christian HeidbrederChief Scientific Officer | 209.3K | – | Jul 10, 2026 | Form 4 |
| Georges GemayelDirector | 42.0K | – | Nov 2, 2026 | Form 4 |
| Carrolee BarlowDirector | 41.7K | – | Nov 2, 2026 | Form 4 |
| Frank MottolaSVP, Chief Tech. Ops. Officer | 30.1K | – | Nov 2, 2026 | Form 4 |
| Padmanabh P. BhattSVP of IP, CSO | 28.7K | – | Nov 2, 2026 | Form 4 |
| Woodrow D AndersonChief Accounting Officer | 27.6K | – | Aug 27, 2026 | Form 4 |
| Jonathan RubinSVP, Chief Medical Officer | 21.5K | – | Nov 2, 2026 | Form 4 |
| Timothy C DecSVP, Chief Financial Officer | 14.1K | – | Nov 2, 2026 | Form 4 |
| Barbara RyanDirector | 5,724 | – | Mar 13, 2026 | Form 4 |
| Stuart A KingsleyDirector | 5,582 | – | Mar 6, 2026 | Form 4 |
A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 312
- Q4 2025: Managers 333
- Q1 2026: Managers 330
- Q2 2026: Managers 334
Institutional investors by quarter
The fund managers holding SUPN, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 334 managers held 60.33M shares, worth $2.8B. During the quarter 47 opened a position, 43 closed one, 115 added and 111 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+6.3%
- Millennium Mgmt (Englander)In the quarter+16%
- Vanguard Portfolio ManagementIn the quarter+2.1%
- Armistice CapitalIn the quarter+40%
- Vanguard Capital ManagementIn the quarter+2.0%
- State StreetIn the quarter+7.5%
- Nomura Asset Management InternationalIn the quarter+17%
- Dimensional Fund AdvisorsIn the quarter-9.9%
- Geode Capital ManagementIn the quarter-3.3%
- Stephens Investment Management GroupIn the quarter+10.0%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 9.35M | +6.3% | $435M |
| Millennium Mgmt (Englander) | 3.85M | +16% | $179M |
| Vanguard Portfolio Management | 3.31M | +2.1% | $154M |
| Armistice Capital | 2.65M | +40% | $123M |
| Vanguard Capital Management | 2.52M | +2.0% | $117M |
| State Street | 2.46M | +7.5% | $114M |
| Nomura Asset Management International | 2.38M | +17% | $111M |
| Dimensional Fund Advisors | 2.08M | -9.9% | $97M |
| Geode Capital Management | 1.57M | -3.3% | $73M |
| Stephens Investment Management Group | 1.49M | +10.0% | $69M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Supernus's filings show?
Who buys and sells is one part of Supernus's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have SUPN's insiders bought or sold?
From Jun 10, 2026 to Nov 4, 2026 Supernus's insiders bought $108.0K and sold $2.8M of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold SUPN?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $85M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.